Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 25 of 50:
15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
Gene Compound Assay Inh Ic50 Ki View
calcium channel, voltage-dependent, L type, alpha 1C subunit TAMOXIFEN Calcium Channel Type L, Dihydropyridine 85% 8.585uM 5.519uM View
adrenergic receptor, alpha 2a LISURIDE Imidazoline I2, Central 85% .001606uM .001071uM View
adrenergic receptor, alpha 2c (Non-specific probe) LISURIDE Imidazoline I2, Central 85% .001606uM .001071uM View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) COBALT(II) ACETYLACETONATE Protein Tyrosine Kinase, HER2 Receptor 85% 3.174uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) COBALT(II) ACETYLACETONATE Protein Tyrosine Kinase, HER2 Receptor 85% 3.174uM NoneNone View
sodium channel, voltage-gated, type I, alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type IX, alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type VII, alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
amiloride-sensitive cation channel 5, intestinal LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type III, beta LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type XI, alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type I, beta LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type 10, alpha polypeptide LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type IV, alpha polypeptide LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type V, alpha polypeptide LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type II, beta LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, nonvoltage-gated 1 alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, nonvoltage-gated 1 gamma LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, nonvoltage-gated 1 beta LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type XI, alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, nonvoltage-gated 1, gamma LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, nonvoltage-gated 1, delta LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, nonvoltage-gated 1 alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type X, alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type IX, alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage gated, type VIII, alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type VII, alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type IV, beta LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type IV, alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type III, alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type II, beta LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type II, alpha 2 LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type I, beta LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type I, alpha LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type IV, beta LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel associated protein 1 LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel associated protein 2 LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
sodium channel, voltage-gated, type III, beta LISURIDE Sodium Channel, Site 2 85% 3.975uM 3.627uM View
opioid receptor, sigma 1 PROMAZINE Sigma1 85% .271uM .114uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) NITRENDIPINE CYP450-2C9 Inhibition 85% .3uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 NITRENDIPINE CYP450-2C9 Inhibition 85% .3uM NoneNone View
dopamine receptor D1A PROMAZINE Dopamine D1 85% 2.464uM 1.232uM View
dopamine receptor D1A NELFINAVIR Dopamine D1 85% 12.935uM 6.467uM View
sodium channel, voltage-gated, type VII, alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
amiloride-sensitive cation channel 5, intestinal PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type III, beta PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type XI, alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type I, beta PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type 10, alpha polypeptide PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type IV, alpha polypeptide PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type V, alpha polypeptide PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type II, beta PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, nonvoltage-gated 1 alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, nonvoltage-gated 1 gamma PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, nonvoltage-gated 1 beta PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type XI, alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, nonvoltage-gated 1, gamma PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, nonvoltage-gated 1, delta PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
potassium voltage-gated channel, subfamily H, member 8 DROPERIDOL Potassium Channel HERG 85% .9272uM .7596uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 DROPERIDOL Potassium Channel HERG 85% .9272uM .7596uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 DROPERIDOL Potassium Channel HERG 85% .9272uM .7596uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 DROPERIDOL Potassium Channel HERG 85% .9272uM .7596uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 DROPERIDOL Potassium Channel HERG 85% .9272uM .7596uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 DROPERIDOL Potassium Channel HERG 85% .9272uM .7596uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 DROPERIDOL Potassium Channel HERG 85% .9272uM .7596uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 DROPERIDOL Potassium Channel HERG 85% .9272uM .7596uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 DROPERIDOL Potassium Channel HERG 85% .9272uM .7596uM View
androgen receptor HEXACHLOROPHENE Testosterone 85% 4.9753uM 3.3169uM View
carbonic anhydrase 5a, mitochondrial ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase 3 ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase 2 ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase 4 ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase XI ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase IX ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase VIII ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase VII ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase VA, mitochondrial ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase IV ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase III, muscle specific ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase I ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase XIV ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase VB, mitochondrial ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase XII ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase VI ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
carbonic anhydrase II ZINC CHLORIDE Carbonic Anhydrase 85% 1.159uM NoneNone View
Cytochrom P450-2D6 monooxygenase VALETHAMATE BROMIDE CYP450-2D6 Inhibition 85% .2485uM NoneNone View
thromboxane A synthase 1 ZAFIRLUKAST Thromboxane Synthetase 85% 3.81uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) ZAFIRLUKAST Thromboxane Synthetase 85% 3.81uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A CINNARIZINE Serotonin 5-HT1A 85% 1.083uM .619uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, gamma subunit 8 DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, gamma subunit 7 DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, gamma subunit 6 DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, gamma subunit 5 DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, gamma subunit 4 DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, gamma subunit 3 DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, gamma subunit 2 DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, gamma subunit 1 DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, beta 4 subunit DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, beta 3 subunit DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, beta 2 subunit DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, alpha 1F subunit DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
calcium channel, voltage-dependent, beta 1 subunit DILTIAZEM Calcium Channel Type L, Phenylalkylamine 85% .63uM .612uM View
Cytochrom P450-2D6 monooxygenase LABETALOL CYP450-2D6 Inhibition 85% .8uM NoneNone View
Cytochrom P450-2C19 monooxygenase PHENYLHYDRAZINE CYP450-2C19 Inhibition 85% 5uM NoneNone View
A3 adenosine receptor IODOQUINOL Adenosine A3 85% .933uM .527uM View
phosphodiesterase 3B BITHIONOL Phosphodiesterase PDE3 85% 2.723uM NoneNone View
phosphodiesterase 3A BITHIONOL Phosphodiesterase PDE3 85% 2.723uM NoneNone View
dopamine receptor D3 BITHIONOL Dopamine D3 85% 4.218uM 1.433uM View
acetylcholinesterase (YT blood group) ETHYLESTRENOL Acetylcholinesterase 85% 6.504uM NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase ETHYLESTRENOL Acetylcholinesterase 85% 6.504uM NoneNone View
acetylcholinesterase ETHYLESTRENOL Acetylcholinesterase 85% 6.504uM NoneNone View
synaptic vesicle glycoprotein 2b FENBENDAZOLE beta-Lactamase 85% 5.994uM NoneNone View
Sigma-2 Receptor BENZTROPINE Sigma2 85% .183uM .112uM View
adrenergic receptor, alpha 2a BENZTROPINE Imidazoline I2, Central 85% 1.925uM 1.284uM View
adrenergic receptor, alpha 2c (Non-specific probe) BENZTROPINE Imidazoline I2, Central 85% 1.925uM 1.284uM View
calcium channel, voltage-dependent, beta 4 subunit OXYMETAZOLINE Calcium Channel Type L, Phenylalkylamine 84% 2.246uM 2.184uM View
calcium channel, voltage-dependent, beta 3 subunit OXYMETAZOLINE Calcium Channel Type L, Phenylalkylamine 84% 2.246uM 2.184uM View
calcium channel, voltage-dependent, beta 2 subunit OXYMETAZOLINE Calcium Channel Type L, Phenylalkylamine 84% 2.246uM 2.184uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit OXYMETAZOLINE Calcium Channel Type L, Phenylalkylamine 84% 2.246uM 2.184uM View
calcium channel, voltage-dependent, alpha 1F subunit OXYMETAZOLINE Calcium Channel Type L, Phenylalkylamine 84% 2.246uM 2.184uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit OXYMETAZOLINE Calcium Channel Type L, Phenylalkylamine 84% 2.246uM 2.184uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit OXYMETAZOLINE Calcium Channel Type L, Phenylalkylamine 84% 2.246uM 2.184uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit OXYMETAZOLINE Calcium Channel Type L, Phenylalkylamine 84% 2.246uM 2.184uM View
calcium channel, voltage-dependent, beta 1 subunit OXYMETAZOLINE Calcium Channel Type L, Phenylalkylamine 84% 2.246uM 2.184uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit OXYMETAZOLINE Calcium Channel Type L, Phenylalkylamine 84% 2.246uM 2.184uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit OXYMETAZOLINE Calcium Channel Type L, Phenylalkylamine 84% 2.246uM 2.184uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 OXYMETAZOLINE Calcium Channel Type L, Phenylalkylamine 84% 2.246uM 2.184uM View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CADMIUM CHLORIDE Protein Tyrosine Kinase, HER2 Receptor 84% 1.334uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CADMIUM CHLORIDE Protein Tyrosine Kinase, HER2 Receptor 84% 1.334uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, gamma subunit 7 LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, gamma subunit 6 LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, gamma subunit 5 LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, gamma subunit 4 LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, gamma subunit 3 LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, gamma subunit 2 LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, gamma subunit 1 LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, beta 4 subunit LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, beta 3 subunit LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, beta 2 subunit LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, alpha 1F subunit LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, beta 1 subunit LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 LACIDIPINE Calcium Channel Type L, Benzothiazepine 84% .005449uM .004843uM View
Sigma-2 Receptor BENZETHONIUM CHLORIDE Sigma2 84% .114uM .07uM View
epidermal growth factor receptor TRIBROMSALAN Protein Tyrosine Kinase, EGF Receptor 84% 2.987uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, gamma subunit 7 NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, gamma subunit 6 NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, gamma subunit 5 NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, gamma subunit 4 NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, gamma subunit 3 NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, gamma subunit 2 NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, gamma subunit 1 NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, beta 4 subunit NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, beta 3 subunit NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, beta 2 subunit NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, alpha 1F subunit NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, beta 1 subunit NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 NISOLDIPINE Calcium Channel Type L, Benzothiazepine 84% .002484uM .002208uM View
5-hydroxytryptamine (serotonin) receptor 1B ASTEMIZOLE Serotonin 5-HT1B 84% 1.387uM .63uM View
Cytochrom P450-1A2 monooxygenase NISOLDIPINE CYP450-1A2 Inhibition 84% 1uM NoneNone View
adrenergic receptor, alpha 2b DISULFIRAM Adrenergic alpha2B 84% 3.218uM 1.469uM View
interleukin 8 receptor, beta DISULFIRAM Chemokine CXCR2 (IL-8B) 84% 6.013uM 4.209uM View
opioid receptor, kappa 1 DISULFIRAM Opiate kappa 84% 6.103uM 2.441uM View
calcium channel, voltage-dependent, alpha 1F subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Benzothiazepine 84% 6.131uM 5.45uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Benzothiazepine 84% 6.131uM 5.45uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Benzothiazepine 84% 6.131uM 5.45uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Benzothiazepine 84% 6.131uM 5.45uM View
calcium channel, voltage-dependent, beta 1 subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Benzothiazepine 84% 6.131uM 5.45uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Benzothiazepine 84% 6.131uM 5.45uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Benzothiazepine 84% 6.131uM 5.45uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DEXCHLORPHENIRAMINE Calcium Channel Type L, Benzothiazepine 84% 6.131uM 5.45uM View
phosphodiesterase 5A, cGMP-specific ZAPRINAST Phosphodiesterase PDE5 84% 1.349uM NoneNone View
phosphodiesterase 5A, cGMP-specific ZAPRINAST Phosphodiesterase PDE5 84% 1.349uM NoneNone View